Remember
 

$ALLK Allakos announced positive Phase 2 results for AK002 in patients with Xolair refractory chronic spontaneous urticaria.”


 More than a wk ago by corporatealerts  •  Posted on Monday, February 11th at 7:04 AM MST  •  0 REACTIONS

React to the Post Above with Your Unique Insight
 

Global Streams

 
PulseStream
SpecStream
UserStream
Reactions
EchoStream